Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients

Peer Review reports

Original Submission
19 Jan 2021	Submitted	Original manuscript
17 Feb 2021	Reviewed	Reviewer Report
27 Apr 2021	Author responded	Author comments - Mireia Massot Mesquida
Resubmission - Version 2
27 Apr 2021	Submitted	Manuscript version 2
29 Apr 2021	Author responded	Author comments - Mireia Massot Mesquida
Resubmission - Version 3
29 Apr 2021	Submitted	Manuscript version 3
10 May 2021	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
11 May 2021	Editorially accepted
22 May 2021	Article published	10.1186/s12877-021-02287-7

Back to article page